Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
Aim: To investigate the relationship of sodium/iodide symporter (NIS) expression with molecular phenotype of highly and low malignant cell lines of human breast cancer (BC) with different sensitivity to doxorubicin (Dox). Materials and Methods: The cell lines used in the analysis included T47D, MCF-...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2016 |
| ISSN: | 1812-9269 |
| Main Authors: | Lukianova, N.Yu., Andriiv, A.V., Chekhun, V.F. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2016
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/137741 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin / N.Yu. Lukianova, A.V. Andriiv, V.F. Chekhun // Experimental Oncology. — 2016 — Т. 38, № 3. — С. 169-171. — Бібліогр.: 18 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017)
by: Yu. Lukianova, et al.
Published: (2017)
Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)
by: Rusetskaya, N.V., et al.
Published: (2011)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
by: Yu, Z., et al.
Published: (2007)
by: Yu, Z., et al.
Published: (2007)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Comparative study of dye-loaded liposome accumulation in sensitive and resistant human breast cancer cells
by: Yefimova, S.L., et al.
Published: (2012)
by: Yefimova, S.L., et al.
Published: (2012)
Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
by: Medviediev, O., et al.
Published: (2016)
by: Medviediev, O., et al.
Published: (2016)
Expression of E-cadherin in drug resistant human breast cancer cells and their sensitivity to lymphokine-activated lymphocytes action
by: Berezhnaya, N.M., et al.
Published: (2009)
by: Berezhnaya, N.M., et al.
Published: (2009)
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)
by: Bereznaya, N.M., et al.
Published: (2008)
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015)
by: Todor, I.N., et al.
Published: (2015)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)
by: S. V. Chekhun, et al.
Published: (2014)
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009)
by: Lukyanova, N.Yu., et al.
Published: (2009)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
by: V. F. Chekhun, et al.
Published: (2016)
by: V. F. Chekhun, et al.
Published: (2016)
Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
by: Rusetskaya, N.V., et al.
Published: (2009)
by: Rusetskaya, N.V., et al.
Published: (2009)
Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
by: Boroday, N.V., et al.
Published: (2018)
by: Boroday, N.V., et al.
Published: (2018)
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: I. V. Chorna, et al.
Published: (2014)
by: I. V. Chorna, et al.
Published: (2014)
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: Chorna, I.V., et al.
Published: (2014)
by: Chorna, I.V., et al.
Published: (2014)
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010)
by: Lukyanova, N.Yu.
Published: (2010)
Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: Ryabtseva, O.D., et al.
Published: (2013)
by: Ryabtseva, O.D., et al.
Published: (2013)
Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: Burlaka, A.P., et al.
Published: (2015)
by: Burlaka, A.P., et al.
Published: (2015)
Sensitization of human malignant lymphoid cells to etoposide by fucoidan, a brown seaweed polysaccharide
by: Philchenkov, A., et al.
Published: (2007)
by: Philchenkov, A., et al.
Published: (2007)
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristic
by: Pamuk, G.E., et al.
Published: (2006)
by: Pamuk, G.E., et al.
Published: (2006)
Survivin expression in ovarian cancer
by: Liguang, Z., et al.
Published: (2007)
by: Liguang, Z., et al.
Published: (2007)
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)
by: Ryspayeva, D.E., et al.
Published: (2017)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymph
by: Shlapatska, L.M., et al.
Published: (2006)
by: Shlapatska, L.M., et al.
Published: (2006)
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
by: Timovska, Yu.O., et al.
Published: (2009)
by: Timovska, Yu.O., et al.
Published: (2009)
Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
by: Fishchuk, L.E., et al.
Published: (2013)
by: Fishchuk, L.E., et al.
Published: (2013)
Aspisol inhibits tumor growth and induces apoptosis in breast cancer
by: Zhu, X.G., et al.
Published: (2008)
by: Zhu, X.G., et al.
Published: (2008)
Chromosomal Radiosensitivity in Ukrainian breast cancer patients and healthy Individuals
by: Ryabchenko, N.M., et al.
Published: (2012)
by: Ryabchenko, N.M., et al.
Published: (2012)
Similar Items
-
Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
by: Chekhun, V.F., et al.
Published: (2017) -
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012) -
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016) -
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016) -
The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017)